Abstract:
Introduction: I studied a clinical case of non-Hodgkin T-cell with primary damage to the skin. This
pathology is a malignant tumor that develops from hematopoietic cells (T lymphocyte) which are located
extra medullary. Is found very rarely (0.2 - 0.4 to 100,000 of total population) and 1 to 2.2% of all lymphomas.
Purpose and objectives: To study a case report with Non-Hodgkin’s lymphoma T-cell with primary
skin damage, from the clinical perspective and treatment efficacy. To analyze different treatment schemes:
CHOP, CHOEP, CVAMP, VAMP and Roferon.
Materials and methods: Clinical case.
Results: We established the following diagnosis: Non-Hodgkins lymphoma T-cell with primary skin
damage, with progression in the lungs, stage - VI A.
Conclusions: A. It was found lymphoma Non-Hodgkin T-cell with primary skin damage, with progression in the lungs, stage - VI A; B. The priorities of the treatment with Roferon in association with the
next schemes of treatment, CHOP “, CHOEP”, CVAMP “, VAMP”.
